Supernus Pharmaceuticals Selects DSG, Inc. for EDC and IWRS in Phase 3 Clinical Studies on Impulsive Aggression in Pediatric Patients Treated for Attention Deficit/Hyperactivity Disorder (ADHD)

MALVERN, Pa.--(BUSINESS WIRE)--DSG, a leader in electronic data capture, was selected by Supernus Pharmaceuticals, a specialty pharmaceutical company, to provide a fully supported eCaseLink EDC system for 2 blinded Phase 3 studies.

Image may be NSFW.
Clik here to view.Image may be NSFW.
Clik here to view.